Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

Contact Supplier

Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

7DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

API REF. PRICE (USD/KG)

$ 0

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Regulatory FDF Prices

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

API

FDF

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Cft7455, 2504235-67-8, D86mf5h9wj, Cft-7455, (3s)-3-(6-((4-(morpholin-4-ylmethyl)phenyl)methyl)-2-oxobenzo(cd)indol-1-yl)piperidine-2,6-dione, 2,6-piperidinedione, 3-(6-((4-(4-morpholinylmethyl)phenyl)methyl)-2-oxobenz(cd)indol-1(2h)-yl)-, (3s)-

Molecular Formula

C₂₈H₂₇N₃O₄

Molecular Weight

469.5 g/mol

InChI Key

MUKCJOOKCZSQNW-DEOSSOPVSA-N

FDA UNII

D86MF5H9WJ

CEMSIDOMIDE is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications.

1 2D Structure

Cemsidomide

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(3S)-3-[6-[[4-(morpholin-4-ylmethyl)phenyl]methyl]-2-oxobenzo[cd]indol-1-yl]piperidine-2,6-dione

2.1.2 InChI

InChI=1S/C28H27N3O4/c32-25-11-10-24(27(33)29-25)31-23-9-8-20(21-2-1-3-22(26(21)23)28(31)34)16-18-4-6-19(7-5-18)17-30-12-14-35-15-13-30/h1-9,24H,10-17H2,(H,29,32,33)/t24-/m0/s1

2.1.3 InChI Key

MUKCJOOKCZSQNW-DEOSSOPVSA-N

2.2 Other Identifiers

2.2.1 UNII

D86MF5H9WJ

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Cft7455

2. 2504235-67-8

3. D86mf5h9wj

4. Cft-7455

5. (3s)-3-(6-((4-(morpholin-4-ylmethyl)phenyl)methyl)-2-oxobenzo(cd)indol-1-yl)piperidine-2,6-dione

6. 2,6-piperidinedione, 3-(6-((4-(4-morpholinylmethyl)phenyl)methyl)-2-oxobenz(cd)indol-1(2h)-yl)-, (3s)-

7. (3s)-3-[6-[[4-(morpholin-4-ylmethyl)phenyl]methyl]-2-oxobenzo[cd]indol-1-yl]piperidine-2,6-dione

8. 2,6-piperidinedione, 3-[6-[[4-(4-morpholinylmethyl)phenyl]methyl]-2-oxobenz[cd]indol-1(2h)-yl]-, (3s)-

9. Refchem:1081326

10. (s)-3-(6-(4-(morpholinomethyl)benzyl)-2-oxobenzo[cd]indol-1(2h)-yl)piperidine-2,6-dione

11. Unii-d86mf5h9wj

12. Cemsidomida

13. Cemsidomide [inn]

14. Cft7455; Cemsidomide

15. Cemisidomide (usan/inn)

16. Cemsidomide [usan]

17. Cft 7455

18. Orb1301216

19. Chembl5095227

20. Schembl22549709

21. Schembl29881140

22. Gtpl11961

23. Glxc-26095

24. (s)-cft7455

25. Ex-a6043

26. Nsc840579

27. Akos040758857

28. At41376

29. Nsc-840579

30. Bp-28982

31. Da-51799

32. Ms-28680

33. Hy-144841

34. Cs-0435593

35. D12933

36. En300-43393872

37. F987600

38. (3s)-3-(6-{[4-(morpholin-4-ylmethyl)phenyl]methyl}-2-oxobenz[cd]indol-1(2h)-yl]piperidine-2,6-dione

39. (3s)-3-[6-[[4-(4-morpholinylmethyl)phenyl]methyl]-2-oxobenz[cd]indol-1(2h)-yl]-2,6-piperidinedione

40. (3s)-3-[6-[[4-(morpholinomethyl)phenyl]methyl]-2-oxo-benzo[cd]indol-1-yl]piperidine-2,6-dione

41. (3s)-3-[9-({4-[(morpholin-4-yl)methyl]phenyl}methyl)-3-oxo-2-azatricyclo[6.3.1.0,4,12]dodeca-1(12),4,6,8,10-pentaen-2-yl]piperidine-2,6-dione

2.4 Create Date

2020-12-19

3 Chemical and Physical Properties

Molecular Formula	C₂₈H₂₇N₃O₄
Molecular Weight	469.5 g/mol
XLogP3	2.9
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	5
Exact Mass	Da
Monoisotopic Mass	Da
Topological Polar Surface Area	79
Heavy Atom Count	35
Formal Charge	0
Complexity	819
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1